Literature DB >> 23193704

Molecular targeted therapy in lung cancer.

Naomi Fujioka1, Peter B Bitterman.   

Abstract

Genetic sequencing has allowed better understanding of non-small-cell lung cancer, leading to improvements in the ability to diagnose and treat the disease through targeted therapy. This article describes some of the past and ongoing studies of targeted therapies for lung cancers, the genetic mutations in lung cancers that develop in people who never smoked, and the role of Minnesota researchers in understanding the pathogenesis of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23193704

Source DB:  PubMed          Journal:  Minn Med        ISSN: 0026-556X


  2 in total

1.  Tanshinones suppress AURKA through up-regulation of miR-32 expression in non-small cell lung cancer.

Authors:  Zhong-Liang Ma; Bing-Jie Zhang; D Tao Wang; Xue Li; Jia-Li Wei; Bo-Tao Zhao; Yan Jin; Yan-Li Li; You-Xin Jin
Journal:  Oncotarget       Date:  2015-08-21

2.  The Efficacy and Safety of Anlotinib Alone and in Combination with Other Drugs in Advanced Lung Cancer: A Retrospective Cohort Study.

Authors:  Lei Li; Hui Zhang; Yalin Xie; Ning Su; Shan Su; Xianlan Zhang; Wenchang Cen
Journal:  Comput Math Methods Med       Date:  2022-02-25       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.